Skip to main content
Costantine Albany, MD, Oncology, Lafayette, IN, Eskenazi Health

CostantineAlbanyMD(He/Him)

Oncology Lafayette, IN

Genitourinary Oncology, Hematologic Oncology, Melanoma

Hematology-Oncology Horizon Oncology Center

Dr. Albany is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Albany's full profile

Already have an account?

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2007 - 2010
  • University of Tichreen Faculty of Medicine
    University of Tichreen Faculty of MedicineClass of 2002

Certifications & Licensure

  • WA State Medical License
    WA State Medical License Current
  • IN State Medical License
    IN State Medical License 2013 - 2026
  • IN State Medical License
    IN State Medical License 2010 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Career Development Award ASCO, 2014
  • Merit Award Conquer Cancer Foundation of ASCO, 2012
  • Travel Award Indiana University Simon Cancer Center, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting  
    Rudolph M Navari, Costantine Albany, Charles L Loprinzi, JAMA Oncology
  • Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  
    Richard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
  • Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy  
    Shalaby A, El-Saed A, Voigt A, Albany C, Saba S, Pacing Clin Electrophysiol (PACE), 1/1/2008

Books/Book Chapters

Abstracts/Posters

  • Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors.
    Costantine Albany, Darren Feldman, Lawrence Garbo, Lawrence Einhorn, GU ASCO, 1/1/2013
  • A retrospective analysis of patients with intermediate risk germ cell tumor (IRGCT) treated at Indiana university from 2000-2010.
    Costantine Albany, Shailesh R. Satpute, Mary J. Brames, Yaman Suleiman, Nawar Al Nasrallah, Susan M. Perkins, Nasser H. Hanna, Lawrence H. Einhorn, ASCO, 1/1/2012
  • Overall survival (OS) prognostic factors in metastatic castrate resistant prostate cancer (mCRPC) patients retreated with docetaxel (D).
    Shilpa Rashmikant Shah, Costantine Albany, Noah M. Hahn, ASCO, 1/1/2012

Lectures

  • Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy. 
    2019 ASCO Annual Meeting - 6/1/2019
  • "Update on the Treatment of Prostate Cancer" 
    1/20/2013
  • Grand Round: "Dissecting the molecular pathways of testicular germ cell tumor pathogenesis; from initiation to treatment resistance" 
    Indiana University Simon Cancer Center - 1/4/2013
  • Join now to see all

Authored Content

  • Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or VomitingMay 2020
  • Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or VomitingMay 2020

Professional Memberships

Hospital Affiliations